Étudier la mémoire et l'activité physique après le traitement du cancer chez les survivants des cancers des adolescents et des jeunes adultes (IMPACT)
This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Clinical Trials Referral Office
- Numéro de téléphone: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
Sauvegarde des contacts de l'étude
- Nom: Melissa Cole
- Numéro de téléphone: 480-574-4052
- E-mail: mailto:ARZENL@mayo.edu
Lieux d'étude
-
-
Arizona
-
Scottsdale, Arizona, États-Unis, 85259
- Recrutement
- Mayo Clinic in Arizona
-
Contact:
- Clinical Trials Referral Office
- Numéro de téléphone: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
-
Contact:
- Melissa Cole
- Numéro de téléphone: 480-574-4052
- E-mail: mailto:ARZENL@mayo.edu
-
Chercheur principal:
- Diane K. Ehlers, PhD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Patients with primary diagnosis of cancer when 15-39 years old.
La description
Inclusion Criteria:
- Adults (aged 18+ years)
- Primary diagnosis of cancer when 15-39 years-old
- Access to a desktop computer or laptop with reliable internet access
- No gross motor impairments that prohibit ambulation
- Willing to complete study requirements
- English speaking
Exclusion Criteria:
- Diagnosed with nonmelanoma skin cancer only
- Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years
- Scheduled travel during the study period that is not indicative of individual's normal schedule
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_ONLY
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Observational
Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study. |
Non-Interventional Study |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cognitive performance on Stroop task
Délai: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
Up to 4 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cognitive performance on Visual Memory Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Verbal Memory Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Symbol Digit Coding Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Shifting Attention Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Continuous Performance Test
Délai: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). |
Up to 4 weeks
|
|
Cognitive performance on Reasoning Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Four Part Continuous Performance Test
Délai: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Self-reported cognition - FACT-COG
Délai: 2 weeks
|
Evaluated using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG), a 37-item questionnaire assessing cognitive impairment, cognitive abilities, and quality of life over the past 7 days. Responses are on a 5-point scale (Never; About once a week; Two to three times a week; Nearly every day; Several times a day). Higher scores generally indicate better self-reported cognition. |
2 weeks
|
|
Average weekly minutes of physical activity
Délai: 2 weeks
|
Moderate-to-vigorous physical activity (MVPA) will be measured using an accelerometer (activPAL) which participants will wear on their non-dominant thigh for 7 consecutive days. |
2 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Diane K. Ehlers, PhD, Mayo Clinic
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 24-008654
- 24-008654 (Autre identifiant: Mayo Clinic Institutional Review Board)
- NCI-2025-01193 (Identificateur de registre: CTRP (Clinical Trial Reporting Program))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
De-identified, limited datasets will be shared with other researchers upon request or according to journal publication requirements
Délai de partage IPD
At time of first publication (as required by journals) until last manuscript is published.
Critères d'accès au partage IPD
If required by journal and case by case upon request to the PI
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .